| SR | sarcoplasmic reticulum; saturation recovery; scanning radiometer; screen; secretion rate; sedimentat... |
|---|---|
| GIH | Growth hormone release Inhibiting Hormone = Somatostatin |
| GnRH | Gonadotropin Releasing Hormone [HP 1898, 2034] = LHRH = Go... |
| PIF | 1) Proliferation Inhibitory Factor 2) Prolactin release Inhibiting Factor... |
| SRIF | Somatotropin Release-Inhibitory Factor = Somatostatin |
| APRV | Airway Pressure Release Ventilation |
|---|---|
| BRP | bacteriocin release protein |
| CICR | Ca induced Ca release |
| CICR | Ca(+2)-induced Ca+2 release |
| CRC | Ca(2+)-release channel |
| biochemical phenomena | Biochemical functions, activities, and processes at organic and molecular levels in humans, animals, microorganisms, and plants. (12 Dec 1998) |
|---|---|
| biological phenomena | Biological functions and activities at the organic and molecular levels in humans, animals, microorganisms, and plants. For biochemical and metabolic processes, biochemical phenomena is available. (12 Dec 1998) |
| chemical and pharmacologic phenomena | Chemical, pharmacologic, and metabolic action and interaction of drugs. (12 Dec 1998) |
| microbiologic phenomena | Physiological processes and activities of microorganisms, including archaea, bacteria, rickettsia, viruses, protozoa, and fungi. (12 Dec 1998) |
| cooperative phenomena | <radiobiology> The effects of interacting particles acting collectively, rather than individually. Includes plasma oscillations, turbulence, and instabilities. (Plasmas are distinguished from collections of individual particles in that they exhibit cooperative phenomena in which the plasma participates as a unified entity.) Early fusion researchers who devised fusion schemes based upon theories where plasmas acted as merely a collection of individual particles (and therefore sought to confine only individual particles) often found themselves frustrated at the ability of plasma cooperative phenomena (such as magnetohydrodynamic instabilities) to thwart their efforts. (09 Oct 1997) |
| psychological phenomena and processes | Mechanisms and underlying psychological principles of mental processes and their applications. (12 Dec 1998) |
| carpal tunnel release | <orthopaedics, procedure> An orthopaedic surgical procedure which relieves the pressure exerted on the median nerve within the carpal tunnel in the wrist. This surgery may be performed conventionally via a small incision or using a fibreoptic scope (endoscopic carpal tunnel repair). (08 Jan 1998) |
| Release | <chemical> Abscission agent for loosening citrus fruit before harvesting Synonym: 5-chloro-3-methyl-4-nitro-1h-pyrazole (26 Jun 1999) |
| release factor | A component of the specialised transport system involved in the transport of cobalamin (vitamin B12) across the wall of the intestine. Dissociates the complex between cobalamin and the extracellular cobalamin binding glycoprotein known as intrinsic factor. (18 Nov 1997) |
| release phenomenon | The increased tonus and hyperirritability of muscle-stretch reflexes which occur following damage of the upper portions of the extrapyramidal system. (05 Mar 2000) |
| melanotropin release-inhibiting hormone | Inhibits synthesis and release of melanotropin. Synonym: melanotropin release-inhibiting hormone. Origin: melanotropin + G. States, stationary, + -in (05 Mar 2000) |
| ryanodine receptor calcium release channel | Protein complexes that mediate the release of calcium from the sarcoplasmic reticulum in both skeletal and cardiac muscle cells by forming tetrametric complexes. These complexes each then act as a calcium channel. There are three isoforms of the ryr: ryr1, ryr2, and ryr3. Ryr1 is specifically expressed in skeletal muscles and ryr2 in cardiac muscles. Ryr3 is yet another isoform found in non-muscle cells such as neuronal cells. (12 Dec 1998) |
| pituitary hormone release inhibiting hormones | Polypeptide hormones produced in the hypothalamus which inhibit the release of pituitary hormones. (12 Dec 1998) |
| msh release-inhibiting hormone | <chemical> An oligopeptide hormone produced in the hypothalamus that inhibits the release of melanocyte-stimulating hormone (msh). Chemical name: Melanostatin (12 Dec 1998) |
| control release suture | Eyeless suture with thread attached to needle such that the two separate when tension is applied to the thread. (05 Mar 2000) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|